TYRA
NASDAQStockTyra Biosciences, Inc.
$35.92-0.62 (-1.70%)
52-Week Range
$7.06
$36.54
Key Stats
Market Cap
1.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.06
Volume
582.3K
Avg Volume
1.3M
Performance
1M
+20.00%
3M
+62.75%
6M
+192.45%
YTD
+34.38%
1Y
+235.20%
3Y
+162.58%
5Y
+38.46%
Price Chart
ETF Exposure
TYRA is held by 54 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | 1.19% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.14% |
| CANC | Tema Oncology ETF | 0.62% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.51% |
| IWC | iShares Micro-Cap ETF | 0.19% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.14% |
| IBB | iShares Biotechnology ETF | 0.11% |
| XBI | State Street SPDR S&P Biotech ETF | 0.11% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.10% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.07% |
| IWN | iShares Russell 2000 Value ETF | 0.06% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.03% |
| RSSL | Global X - Russell 2000 ETF | 0.03% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.03% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.02% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.02% |
| PWS | Pacer WealthShield ETF | 0.02% |
| URTY | ProShares - UltraPro Russell2000 | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
Page 1 of 2Next
About TYRA ETF Exposure
Tyra Biosciences, Inc. (TYRA) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.9B, TYRA is a widely held institutional stock. The stock currently trades at $35.92. Investors can gain exposure to TYRA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TYRA, sorted by portfolio weight.